# Impact of Enhanced External Counterpulsation on Vascular Hemodynamics and Status

Study · id `cardio:ct-nct03102502` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03102502](<https://clinicaltrials.gov/study/NCT03102502>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03102502

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

## Technical summary

Registry record NCT03102502. Randomized; single masking; primary purpose treatment. Start 2017-03-10 (actual); primary completion 2018-10-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 110 participants (enrolled count; ClinicalTrials.gov record NCT03102502, source copy `cardio:ctgov-nct03102502-2020-11-02`, retrieved 2026-10-31)
- Started: 2017-03-10 (actual) (ClinicalTrials.gov record NCT03102502, source copy `cardio:ctgov-nct03102502-2020-11-02`, retrieved 2026-10-31)
- Primary completion: 2018-10-10 (actual) (ClinicalTrials.gov record NCT03102502, source copy `cardio:ctgov-nct03102502-2020-11-02`, retrieved 2026-10-31)
- Completion: 2019-01-10 (actual) (ClinicalTrials.gov record NCT03102502, source copy `cardio:ctgov-nct03102502-2020-11-02`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT03102502, source copy `cardio:ctgov-nct03102502-2020-11-02`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03102502-2020-11-02`, retrieved 2026-10-31)

## The registry's words

- Brief title: Impact of Enhanced External Counterpulsation on Vascular Hemodynamics and Status
- Acronym: EECPVHS
- Condition: Coronary Heart Disease
- Intervention (Device): EECP
- Intervention (Drug): Medical therapy
- Lead sponsor: Sun Yat-sen University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry lists this organization as the lead sponsor: Sun Yat-sen University (`cardio:org-sun-yat-sen-university`)

## Provenance

Content hash: 351a9f197aaeefc49d57e560707f02523d0edaa0246697acc174c177f1e687e2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
